R&D Systems™ Recombinant Canine GM-CSF Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Product Code	Brand	Formulation
18381318	R&D Systems™ 1546-GM-025	Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein.
18166970	R&D Systems™ 1546-GM-025/CF	Lyophilized from a 0.2μm filtered solution in PBS.

Description

The Recombinant Canine GM-CSF Protein is derived from E. coli. The Recombinant Canine GM-CSF Protein has been validated for the following applications: Bioactivity.

Specifications

• Gene ID (Entrez): 403923
• Name: GM-CSF
• Source: E. coli-derived canine GM-CSF protein Ala18-Lys144
• Endotoxin Concentration: <0.01 EU per 1μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Purity or Quality Grade: 97%, by SDS-PAGE under reducing conditions and visualized by silver stain.

• Molecular Weight (g/mol): 14.2 kDa
• Quantity: 25μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Gene Alias: colony stimulating factor 2 (granulocyte-macrophage), Colony-stimulating factor, CSF, CSF2, CSF-2, GMCSF, GM-CSF, GMCSFgranulocyte-macrophage colony-stimulating factor, granulocyte-macrophage colony stimulating factor, MGC131935, MGC138897, Molgramostim, molgramostin, sargramostim
• Recombinant: Recombinant